ArticleJournal of neuroengineering and rehabilitation2025
Development and validation of the electrosacrogram (ESG): a digital point-of-care tool for real-time neuro-sacral assessment after spinal cord injury.
Article in Journal of neuroengineering and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate assessment of neuro-sacral function after spinal cord injury/lesion and cauda equina (SCI+) is essential for diagnosis, prognosis and early management. The current bedside standard, the digital rectal examination (DRE), is subjective, invasive, and examiner dependent. Surface electromyography (s-EMG) offers a quantitative alternative but has lacked point-of-care integration. We developed the ElectroSacroGram (ESG), a bedside digital s-EMG tool enabling real-time objective assessment of sacral somatic function after SCI+. This study aimed to (1) develop the ESG protocol based on clinical consensus; and (2) evaluate its diagnostic performance compared to radiological findings and expert-performed DRE.
methodsIn this prospective proof-of-concept diagnostic study at a specialized Level 1 trauma center, 52 adults with suspected SCI + and 21 healthy participants underwent ESG and DRE. ESG quantified sacral motor (resting external anal sphincter tone, maximal voluntary anal contraction (maxVAC), reflex (bulbospongious or bulbocavernosus reflex (BSR)), and sensory (electrical perceptual threshold (EPT)) function using low-intensity electrical stimulation. Clinically relevant DRE parameters were selected by an expert panel. Content validity was assessed using item/scale content validity indices (CVI), agreement with DRE (Cohen's κ) and diagnostic accuracy were calculated against imaging-confirmed spinal lesions.
resultsNormative ESG values were established in healthy participants. Neurologically impaired patients showed reduced maxVAC and BSR amplitudes and elevated EPT. ESG demonstrated excellent content validity (S-CVI = 1.00), strong agreement with DRE for VAC (κ = 0.876) and EPT (κ = 0.881), and high diagnostic accuracy (sensitivity 83.3%, specificity 100%, overall accuracy 86.5%).
conclusionsESG enables precise, reproducible evaluation of sacral motor, reflex, and sensory integrity in real-time at bedside. By complementing and objectifying the DRE, it offers a promising precision-medicine tool for early neuro-sacral assessment, enhancing clinical research and improving SCI + diagnosis, for the acute phase and in the context of spinal shock.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.